Dermal Necrosis Treatment Market - Global Outlook and Forecast 2022-2028

March 2022 | 64 pages | ID: DC54E953B23AEN
Market Monitor Global

Abstracts

Acute cutaneous necrosis can be defined as a skin disease with sudden onset of tissue death that results in significant morbidity and is usually, but not always, excruciatingly painful. Early diagnosis can allow for early therapy and can decrease the chances of morbidity and loss of life. A thorough history is mandatory including recent reavel, drugs, underlying illnesses and recent surgical procedures. Blood tests that are often helpful are creatinine phosphokinase, blood cultures, antinuclear antibodies, rheumatoid factor, antinuclear cytoplasmic antibodies, hypercoagulability screen, creatinine, complete blood count and human immunodeficiency virus test. Other procedures such as computerized axial tomography and magnetic resonance imaging also helps to determine the extent of disease.

This report contains market size and forecasts of Dermal Necrosis Treatment in Global, including the following market information:

Global Dermal Necrosis Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Dermal Necrosis Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Immunosuppressive Agents Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Dermal Necrosis Treatment include Baxter, Boston Therapeutics, Amgen, AstraZeneca, Glaxo Smithkline Pharmaceuticals, Systopic Laboratories, Sun Pharmaceuticals, RPG Life Sciences and Zydus Cadila. etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Dermal Necrosis Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Dermal Necrosis Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Dermal Necrosis Treatment Market Segment Percentages, by Type, 2021 (%)

• Immunosuppressive Agents
• Corticosteroids

Global Dermal Necrosis Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Dermal Necrosis Treatment Market Segment Percentages, by Application, 2021 (%)

• Hospital
• Clinics
• Ambulatory Surgery Center

Global Dermal Necrosis Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Dermal Necrosis Treatment Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Dermal Necrosis Treatment revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Dermal Necrosis Treatment revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Baxter
• Boston Therapeutics
• Amgen
• AstraZeneca
• Glaxo Smithkline Pharmaceuticals
• Systopic Laboratories
• Sun Pharmaceuticals
• RPG Life Sciences
• Zydus Cadila

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Dermal Necrosis Treatment Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Dermal Necrosis Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL DERMAL NECROSIS TREATMENT OVERALL MARKET SIZE

2.1 Global Dermal Necrosis Treatment Market Size: 2021 VS 2028
2.2 Global Dermal Necrosis Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Dermal Necrosis Treatment Players in Global Market
3.2 Top Global Dermal Necrosis Treatment Companies Ranked by Revenue
3.3 Global Dermal Necrosis Treatment Revenue by Companies
3.4 Top 3 and Top 5 Dermal Necrosis Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Dermal Necrosis Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Dermal Necrosis Treatment Players in Global Market
  3.6.1 List of Global Tier 1 Dermal Necrosis Treatment Companies
  3.6.2 List of Global Tier 2 and Tier 3 Dermal Necrosis Treatment Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Dermal Necrosis Treatment Market Size Markets, 2021 & 2028
  4.1.2 Immunosuppressive Agents
  4.1.3 Corticosteroids
4.2 By Type - Global Dermal Necrosis Treatment Revenue & Forecasts
  4.2.1 By Type - Global Dermal Necrosis Treatment Revenue, 2017-2022
  4.2.2 By Type - Global Dermal Necrosis Treatment Revenue, 2023-2028
  4.2.3 By Type - Global Dermal Necrosis Treatment Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Dermal Necrosis Treatment Market Size, 2021 & 2028
  5.1.2 Hospital
  5.1.3 Clinics
  5.1.4 Ambulatory Surgery Center
5.2 By Application - Global Dermal Necrosis Treatment Revenue & Forecasts
  5.2.1 By Application - Global Dermal Necrosis Treatment Revenue, 2017-2022
  5.2.2 By Application - Global Dermal Necrosis Treatment Revenue, 2023-2028
  5.2.3 By Application - Global Dermal Necrosis Treatment Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Dermal Necrosis Treatment Market Size, 2021 & 2028
6.2 By Region - Global Dermal Necrosis Treatment Revenue & Forecasts
  6.2.1 By Region - Global Dermal Necrosis Treatment Revenue, 2017-2022
  6.2.2 By Region - Global Dermal Necrosis Treatment Revenue, 2023-2028
  6.2.3 By Region - Global Dermal Necrosis Treatment Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Dermal Necrosis Treatment Revenue, 2017-2028
  6.3.2 US Dermal Necrosis Treatment Market Size, 2017-2028
  6.3.3 Canada Dermal Necrosis Treatment Market Size, 2017-2028
  6.3.4 Mexico Dermal Necrosis Treatment Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Dermal Necrosis Treatment Revenue, 2017-2028
  6.4.2 Germany Dermal Necrosis Treatment Market Size, 2017-2028
  6.4.3 France Dermal Necrosis Treatment Market Size, 2017-2028
  6.4.4 U.K. Dermal Necrosis Treatment Market Size, 2017-2028
  6.4.5 Italy Dermal Necrosis Treatment Market Size, 2017-2028
  6.4.6 Russia Dermal Necrosis Treatment Market Size, 2017-2028
  6.4.7 Nordic Countries Dermal Necrosis Treatment Market Size, 2017-2028
  6.4.8 Benelux Dermal Necrosis Treatment Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Dermal Necrosis Treatment Revenue, 2017-2028
  6.5.2 China Dermal Necrosis Treatment Market Size, 2017-2028
  6.5.3 Japan Dermal Necrosis Treatment Market Size, 2017-2028
  6.5.4 South Korea Dermal Necrosis Treatment Market Size, 2017-2028
  6.5.5 Southeast Asia Dermal Necrosis Treatment Market Size, 2017-2028
  6.5.6 India Dermal Necrosis Treatment Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Dermal Necrosis Treatment Revenue, 2017-2028
  6.6.2 Brazil Dermal Necrosis Treatment Market Size, 2017-2028
  6.6.3 Argentina Dermal Necrosis Treatment Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Dermal Necrosis Treatment Revenue, 2017-2028
  6.7.2 Turkey Dermal Necrosis Treatment Market Size, 2017-2028
  6.7.3 Israel Dermal Necrosis Treatment Market Size, 2017-2028
  6.7.4 Saudi Arabia Dermal Necrosis Treatment Market Size, 2017-2028
  6.7.5 UAE Dermal Necrosis Treatment Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Baxter
  7.1.1 Baxter Corporate Summary
  7.1.2 Baxter Business Overview
  7.1.3 Baxter Dermal Necrosis Treatment Major Product Offerings
  7.1.4 Baxter Dermal Necrosis Treatment Revenue in Global Market (2017-2022)
  7.1.5 Baxter Key News
7.2 Boston Therapeutics
  7.2.1 Boston Therapeutics Corporate Summary
  7.2.2 Boston Therapeutics Business Overview
  7.2.3 Boston Therapeutics Dermal Necrosis Treatment Major Product Offerings
  7.2.4 Boston Therapeutics Dermal Necrosis Treatment Revenue in Global Market (2017-2022)
  7.2.5 Boston Therapeutics Key News
7.3 Amgen
  7.3.1 Amgen Corporate Summary
  7.3.2 Amgen Business Overview
  7.3.3 Amgen Dermal Necrosis Treatment Major Product Offerings
  7.3.4 Amgen Dermal Necrosis Treatment Revenue in Global Market (2017-2022)
  7.3.5 Amgen Key News
7.4 AstraZeneca
  7.4.1 AstraZeneca Corporate Summary
  7.4.2 AstraZeneca Business Overview
  7.4.3 AstraZeneca Dermal Necrosis Treatment Major Product Offerings
  7.4.4 AstraZeneca Dermal Necrosis Treatment Revenue in Global Market (2017-2022)
  7.4.5 AstraZeneca Key News
7.5 Glaxo Smithkline Pharmaceuticals
  7.5.1 Glaxo Smithkline Pharmaceuticals Corporate Summary
  7.5.2 Glaxo Smithkline Pharmaceuticals Business Overview
  7.5.3 Glaxo Smithkline Pharmaceuticals Dermal Necrosis Treatment Major Product Offerings
  7.5.4 Glaxo Smithkline Pharmaceuticals Dermal Necrosis Treatment Revenue in Global Market (2017-2022)
  7.5.5 Glaxo Smithkline Pharmaceuticals Key News
7.6 Systopic Laboratories
  7.6.1 Systopic Laboratories Corporate Summary
  7.6.2 Systopic Laboratories Business Overview
  7.6.3 Systopic Laboratories Dermal Necrosis Treatment Major Product Offerings
  7.6.4 Systopic Laboratories Dermal Necrosis Treatment Revenue in Global Market (2017-2022)
  7.6.5 Systopic Laboratories Key News
7.7 Sun Pharmaceuticals
  7.7.1 Sun Pharmaceuticals Corporate Summary
  7.7.2 Sun Pharmaceuticals Business Overview
  7.7.3 Sun Pharmaceuticals Dermal Necrosis Treatment Major Product Offerings
  7.7.4 Sun Pharmaceuticals Dermal Necrosis Treatment Revenue in Global Market (2017-2022)
  7.7.5 Sun Pharmaceuticals Key News
7.8 RPG Life Sciences
  7.8.1 RPG Life Sciences Corporate Summary
  7.8.2 RPG Life Sciences Business Overview
  7.8.3 RPG Life Sciences Dermal Necrosis Treatment Major Product Offerings
  7.8.4 RPG Life Sciences Dermal Necrosis Treatment Revenue in Global Market (2017-2022)
  7.8.5 RPG Life Sciences Key News
7.9 Zydus Cadila
  7.9.1 Zydus Cadila Corporate Summary
  7.9.2 Zydus Cadila Business Overview
  7.9.3 Zydus Cadila Dermal Necrosis Treatment Major Product Offerings
  7.9.4 Zydus Cadila Dermal Necrosis Treatment Revenue in Global Market (2017-2022)
  7.9.5 Zydus Cadila Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Dermal Necrosis Treatment Market Opportunities & Trends in Global Market
Table 2. Dermal Necrosis Treatment Market Drivers in Global Market
Table 3. Dermal Necrosis Treatment Market Restraints in Global Market
Table 4. Key Players of Dermal Necrosis Treatment in Global Market
Table 5. Top Dermal Necrosis Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Dermal Necrosis Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Dermal Necrosis Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Dermal Necrosis Treatment Product Type
Table 9. List of Global Tier 1 Dermal Necrosis Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Dermal Necrosis Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Dermal Necrosis Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Dermal Necrosis Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Dermal Necrosis Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Dermal Necrosis Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Dermal Necrosis Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Dermal Necrosis Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Dermal Necrosis Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Dermal Necrosis Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Dermal Necrosis Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Dermal Necrosis Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Dermal Necrosis Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Dermal Necrosis Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Dermal Necrosis Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Dermal Necrosis Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Dermal Necrosis Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Dermal Necrosis Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Dermal Necrosis Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Dermal Necrosis Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Dermal Necrosis Treatment Revenue, (US$, Mn), 2023-2028
Table 30. Baxter Corporate Summary
Table 31. Baxter Dermal Necrosis Treatment Product Offerings
Table 32. Baxter Dermal Necrosis Treatment Revenue (US$, Mn), (2017-2022)
Table 33. Boston Therapeutics Corporate Summary
Table 34. Boston Therapeutics Dermal Necrosis Treatment Product Offerings
Table 35. Boston Therapeutics Dermal Necrosis Treatment Revenue (US$, Mn), (2017-2022)
Table 36. Amgen Corporate Summary
Table 37. Amgen Dermal Necrosis Treatment Product Offerings
Table 38. Amgen Dermal Necrosis Treatment Revenue (US$, Mn), (2017-2022)
Table 39. AstraZeneca Corporate Summary
Table 40. AstraZeneca Dermal Necrosis Treatment Product Offerings
Table 41. AstraZeneca Dermal Necrosis Treatment Revenue (US$, Mn), (2017-2022)
Table 42. Glaxo Smithkline Pharmaceuticals Corporate Summary
Table 43. Glaxo Smithkline Pharmaceuticals Dermal Necrosis Treatment Product Offerings
Table 44. Glaxo Smithkline Pharmaceuticals Dermal Necrosis Treatment Revenue (US$, Mn), (2017-2022)
Table 45. Systopic Laboratories Corporate Summary
Table 46. Systopic Laboratories Dermal Necrosis Treatment Product Offerings
Table 47. Systopic Laboratories Dermal Necrosis Treatment Revenue (US$, Mn), (2017-2022)
Table 48. Sun Pharmaceuticals Corporate Summary
Table 49. Sun Pharmaceuticals Dermal Necrosis Treatment Product Offerings
Table 50. Sun Pharmaceuticals Dermal Necrosis Treatment Revenue (US$, Mn), (2017-2022)
Table 51. RPG Life Sciences Corporate Summary
Table 52. RPG Life Sciences Dermal Necrosis Treatment Product Offerings
Table 53. RPG Life Sciences Dermal Necrosis Treatment Revenue (US$, Mn), (2017-2022)
Table 54. Zydus Cadila Corporate Summary
Table 55. Zydus Cadila Dermal Necrosis Treatment Product Offerings
Table 56. Zydus Cadila Dermal Necrosis Treatment Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Dermal Necrosis Treatment Segment by Type in 2021
Figure 2. Dermal Necrosis Treatment Segment by Application in 2021
Figure 3. Global Dermal Necrosis Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Dermal Necrosis Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Dermal Necrosis Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Dermal Necrosis Treatment Revenue in 2021
Figure 8. By Type - Global Dermal Necrosis Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Dermal Necrosis Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Dermal Necrosis Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Dermal Necrosis Treatment Revenue Market Share, 2017-2028
Figure 12. US Dermal Necrosis Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Dermal Necrosis Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Dermal Necrosis Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Dermal Necrosis Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Dermal Necrosis Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Dermal Necrosis Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Dermal Necrosis Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Dermal Necrosis Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Dermal Necrosis Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Dermal Necrosis Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Dermal Necrosis Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Dermal Necrosis Treatment Revenue Market Share, 2017-2028
Figure 24. China Dermal Necrosis Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Dermal Necrosis Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Dermal Necrosis Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Dermal Necrosis Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Dermal Necrosis Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Dermal Necrosis Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Dermal Necrosis Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Dermal Necrosis Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Dermal Necrosis Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Dermal Necrosis Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Dermal Necrosis Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Dermal Necrosis Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Dermal Necrosis Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. Baxter Dermal Necrosis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Boston Therapeutics Dermal Necrosis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Amgen Dermal Necrosis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. AstraZeneca Dermal Necrosis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Glaxo Smithkline Pharmaceuticals Dermal Necrosis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Systopic Laboratories Dermal Necrosis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Sun Pharmaceuticals Dermal Necrosis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. RPG Life Sciences Dermal Necrosis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Zydus Cadila Dermal Necrosis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)